Epoxygenases and peroxisome proliferator-activated receptors in mammalian vascular biology (Q36943169)

17 August 2017

1 reference

title

Epoxygenases and peroxisome proliferator-activated receptors in mammalian vascular biology (English)

1 reference

17 August 2017

Jessica Wray

1 reference

17 August 2017

David Bishop-Bailey

series ordinal

1 reference

17 August 2017

language of work or name

1 reference

14 September 2007

1 reference

17 August 2017

published in

Experimental Physiology

1 reference

17 August 2017

1 reference

17 August 2017

1 reference

17 August 2017

page(s)

148-154

1 reference

Endothelium-derived hyperpolarizing factor in human internal mammary artery is 11,12-epoxyeicosatrienoic acid and causes relaxation by activating smooth muscle BK(Ca) channels

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.038612

Peroxisome proliferator-activated receptors: a critical review on endogenous pathways for ligand generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.038612

Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.038612

A new class of lipid mediators: cytochrome P450 arachidonate metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.038612

The CYP4A isoforms hydroxylate epoxyeicosatrienoic acids to form high affinity peroxisome proliferator-activated receptor ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.038612

The role of PPARs in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.038612

Calcium and Cardiac Excitation-Contraction Coupling

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.038612

14,15-Dihydroxyeicosatrienoic acid activates peroxisome proliferator-activated receptor-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.038612

Cytochrome P450 epoxygenases and vascular tone: novel role for HMG-CoA reductase inhibitors in the regulation of CYP 2C expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.038612

Cytochrome P450 2C is an EDHF synthase in coronary arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.038612

Endothelium-derived hyperpolarizing factor synthase (Cytochrome P450 2C9) is a functionally significant source of reactive oxygen species in coronary arteries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.038612

PPAR delta: an uncompletely known nuclear receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.038612

Cytochrome P450-dependent effects of bradykinin in the rat heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.038612

Slow recovery from inactivation of inward currents in mammalian myocardial fibres.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.038612

Nuclear receptor peroxisome proliferator-activated receptor alpha (PPARalpha) is expressed in resting murine lymphocytes. The PPARalpha in T and B lymphocytes is both transactivation and transrepression competent

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.038612

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.038612

The antiinflammatory effect of laminar flow: the role of PPARgamma, epoxyeicosatrienoic acids, and soluble epoxide hydrolase

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.038612

PPARalpha activators inhibit cytokine-induced vascular cell adhesion molecule-1 expression in human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.038612

Cytochrome P4502C9-derived epoxyeicosatrienoic acids induce the expression of cyclooxygenase-2 in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.038612

Cytochrome P450 epoxygenases 2C8 and 2C9 are implicated in hypoxia-induced endothelial cell migration and angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.038612

Peroxisome proliferator-activated receptors and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.038612

Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.038612

Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.038612

Nitric oxide- and EDHF-mediated arteriolar tone in uremia is unaffected by selective inhibition of vascular cytochrome P450 2C9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.038612

The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.038612

PPARalpha and PPARdelta activators inhibit cytokine-induced nuclear translocation of NF-kappaB and expression of VCAM-1 in EAhy926 endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.038612

Metabolism of arachidonic acid by canine polymorphonuclear leukocytes synthesis of lipoxygenase and omega-oxidized metabolites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.038612

PPARalpha activation abolishes LDL-stimulated IL-8 production via AP-1 deactivation in human aortic smooth muscle cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.038612

P450 subfamily CYP2J and their role in the bioactivation of arachidonic acid in extrahepatic tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.038612

Enhanced postischemic functional recovery in CYP2J2 transgenic hearts involves mitochondrial ATP-sensitive K+ channels and p42/p44 MAPK pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.038612

cDNA cloning, chromosomal mapping, and functional characterization of the human peroxisome proliferator activated receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.038612

Novel glutathione conjugates formed from epoxyeicosatrienoic acids (EETs)

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.038612

Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.038612

Inhibition of vascular smooth muscle cell migration by cytochrome p450 epoxygenase-derived eicosanoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.038612

mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.038612

PPARgamma and PPARdelta negatively regulate specific subsets of lipopolysaccharide and IFN-gamma target genes in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.038612

Molecular cloning, expression, and functional significance of a cytochrome P450 highly expressed in rat heart myocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.038612

Molecular cloning and expression of CYP2J2, a human cytochrome P450 arachidonic acid epoxygenase highly expressed in heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.038612

Cytochrome P450: a novel system modulating Ca2+ channels and contraction in mammalian heart cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.038612

Molecular recognition of fatty acids by peroxisome proliferator-activated receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.038612

Structural determinants of ligand binding selectivity between the peroxisome proliferator-activated receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.038612

Molecular cloning, expression and characterization of an endogenous human cytochrome P450 arachidonic acid epoxygenase isoform

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.038612

The rabbit pulmonary cytochrome P450 arachidonic acid metabolic pathway: characterization and significance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.038612

Metabolism of epoxyeicosatrienoic acids by cytosolic epoxide hydrolase: substrate structural determinants of asymmetric catalysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.038612

10.1113/EXPPHYSIOL.2007.038612

21 January 2018

Identifiers

DOI

1 reference

17 August 2017

1 reference